There were 691 press releases posted in the last 24 hours and 156,706 in the last 365 days.

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday, May 8, 2018

BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.

Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8th at 2:10 p.m. ET. 

The presentation will be webcast and accessible online via the investors section of the Company's website at  A replay will be available for 30 days.  

About Teligent, Inc.

Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website


Damian Finio
Teligent, Inc.
(856) 336-9117  

/EIN News/ --  

Primary Logo

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.